Neo-adjuvant Immunotherapy Master Trial for Localized Cancers
NCT07262489
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Localized Cancer
Interventions
DRUG:
Each therapeutic NEOREM sub-protocol will mention the description of intervention
Sponsor
UNICANCER